Medimpex Pharmaceuticals Private Limited
About Medimpex Pharmaceuticals Private Limited
Data last updated:
Medimpex Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 07 July 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1980PTC022801.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surendra Kumar Jangir and Padmakar Motiram Sawant.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹75,000, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹52,316 (net margin 69.8%) and EBITDA of ₹67,177 (EBITDA margin 89.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 10% over five years.
The company has 6 deals on record (6 secondary share transfers); the latest was in March 2023.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medimpex Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5th Floor Chemco House D.N. Road, Fort, Mumbai, Maharashtra, India – 400001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Medimpex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medimpex Pharmaceuticals Private Limited
FY 2025 filings availableMedimpex Pharmaceuticals Private Limited reported revenue of ₹75,000 (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 38% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67,177 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52,316 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 89.6% | ||||
| Net Profit Margin | 69.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medimpex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medimpex Pharmaceuticals Private Limited
Medimpex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra Kumar Jangir Also directs: Bqube Enterprises LLP, Apeejay Stya Publishing Pvt. Ltd, Walter Bushnell Laboratories Private Limited and 5 more | Director | 05 Nov 2011 | 14 Years 11 Months | Current |
| Padmakar Motiram Sawant Also directs: Walter Bushnell Drugs Private Limited, Walter Bushnell Medicaid Private Limited, P B Waviwell (India ) Ltd and 5 more | Director | 01 Mar 2007 | 19 Years 8 Months | Current |
Auditor
Medimpex Pharmaceuticals Private Limited is audited by Gangaram Chandwani for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gangaram Chandwani | FY 2017 | 031616 |
Shareholding
The shareholding of Medimpex Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medimpex Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Medimpex Pharmaceuticals Private Limited has 6 deals on record (6 secondary share transfers); the latest was in March 2023.
Deals on record (5 of 6)
To see the full deal history of Medimpex Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Medimpex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medimpex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medimpex Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medimpex Pharmaceuticals Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Rajesh Ramawatar Sharma ceased to be Director on 23 Feb 2021.
Frequently asked questions
Medimpex Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 07 July 1980 (46+ years old) and is registered under CIN U24230MH1980PTC022801.
Medimpex Pharmaceuticals has 2 current directors:
- Surendra Kumar Jangir - Director
- Padmakar Motiram Sawant - Director
The latest financial statements of Medimpex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Medimpex Pharmaceuticals is U24230MH1980PTC022801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medimpex Pharmaceuticals was incorporated on 07 July 1980, making it 46+ years old. It is registered with the Registrar of Companies, Mumbai.
Medimpex Pharmaceuticals has 6 deals on record (6 secondary share transfers); the latest was in March 2023.
Rajesh Ramawatar Sharma ceased to be Director on 23 Feb 2021. Ramawatar Dungarmal Sharma ceased to be Director on 11 Nov 2011. Surendra Kumar Jangir was appointed as Director on 05 Nov 2011. Medimpex Pharmaceuticals has 4 board changes on record in total.
The registered office of Medimpex Pharmaceuticals is at 5th Floor Chemco House D.N. Road, Fort, Mumbai, Maharashtra, India – 400001.
Medimpex Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Medimpex Pharmaceuticals is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
